Alembic Pharmaceuticals Ltd

Company Name: Alembic Pharmaceuticals Ltd
OldName:
Group :
Address: Corp Office
Alembic Road
City: Vadodara 390003 Vadodara Gujarat
Tel: 0265-2280550 / 880
Fax: 2281229
Mktg-Email : alembic@alembic.co.in
HR-Email :
Purchase-Email : drigesh.mittal@alembic.co.in
Brands Owned :

About the Company :

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India.

Alembic’s manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

In July 2017, the company has set up a anti cancel manufacturing facility in Panelav in Halol in Gujarat.


Alembic Pharma receives USFDA approval for Pregabalin

Alembic Pharmaceuticals has received USFDA approval for Pregabalin Capsules, indicated for management of neuropathic pain associated with certain illnesses. The ...
Read More

Alembic Pharma receives USFDA approval for Clonazepam

Alembic Pharmaceuticals has received USFDA approval for Clonazepam orally disintegrating tablets which are used for treatment of seizures, adjunct in ...
Read More

Alembic Pharma receives USFDA approval for Solifenacin Succinate

Alembic Pharmaceuticals has received USFDA approval for Solifenacin Succinate tablets which are used for treatment of over-active bladder. The product ...
Read More

Alembic Pharma receives USFDA approval for Bromfenac Ophthalmic Solution

Alembic Pharmaceuticals has received USFDA approval from for Bromfenac Ophthalmic Solution, used for treatment of post-operative inflammation and reduction of ...
Read More

Alembic Pharma receives USFDA approval for Oseltamivir Phosphate

Alembic Pharmaceuticals has received final USFDA approval for Oseltamivir Phosphate capsules, used for treatment of influenza infection. The drug is ...
Read More

Alembic Pharmaceuticals receives USFDA approval for Carbidopa and Levodopa extended-release tablets

Alembic Pharmaceuticals has received USFDA approval for Carbidopa and Levodopa extended-release tablets which is used for treatment of Parkinson’s disease ...
Read More

Alembic Pharma receives USFDA approval for Tadlafil

Alembic Pharmaceuticals has received final USFDA approval for Tadalafil tablets, indicated for the treatment of erectile dysfunction. The drug will ...
Read More

Alembic Pharma receives USFDA approval for Azelastine Hydrochloride

Alembic Pharmaceuticals has received USFDA approval for Azelastine Hydrochloride Ophthalmic Solution used for the treatment of allergic conjunctivitis. The drug ...
Read More

Alembic receives USFDA approval for Acetazolamide

Alembic Pharmaceuticals has received final USFDA approval for Acetazolamide extended-release capsules, used for the treatment of various kinds of glaucoma ...
Read More

Alembic Pharma receives USFDA approval for Pramipexole Dihydrochloride tablets

Alembic Pharmaceuticals has received final USFDA approval for Pramipexole Dihydrochloride extended-release tablets used for the treatment of Parkinson’s disease. The ...
Read More

Alembic raises ₹ 3500 million by private placement

Alembic Pharmaceuticals has raised ₹3500 million through allotment of non-convertible debentures (NCDs) on private placement basis. The NCD committee of ...
Read More

Alembic Pharma receives USFDA approval for Temazepam capsules

Alembic Pharmaceuticals has received USFDA approval for Temazepam capsules which is used for the treatment of insomnia. The drug will ...
Read More

Alembic Pharma receives USFDA approval for Olopatadine Hydrochloride

Alembic Pharmaceuticals has received USFDA approval for Olopatadine Hydrochloride ophthalmic solution, used to treat allergic conjunctivitis. The approved product is ...
Read More

Alembic Pharma recieves USFDA approval for Lacosamide

Alembic Pharmaceuticals Ltd has received final USFDA approval for its Lacosamide tablets, which is indicated as adjunctive therapy in patients ...
Read More

Alembic Pharma receives USFDA approval for Zolmitriptan

Alembic Pharmaceuticals has received USFDA approval for Zolmitriptan Orally Disintegrating tablets, used for the treatment of migraine, in the American ...
Read More

Alembic Pharma receives USFDA approval for Telmisartan and Amlodipine

Alembic Pharmaceuticals has received USFDA approval for its Telmisartan and Amlodipine tablets in the strengths of 40mg/5 mg, 40mg/10 mg, ...
Read More

Alembic Pharma receives USFDA approval for fenofibric acid delayed release capsules

Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good ...
Read More

Alembic Pharma receives USFDA approval for doxycycline

Alembic Pharmaceuticals has received the final USFDA approval for Abbreviated New Drug Application (ANDA) of anti-bacterial Doxycycline capsules USP 75 ...
Read More

Alembic receives USFDA approval for acyclovir ointment

Alembic Pharma has received USFDA approval for its Acyclovir ointment USP, used for the treatment of genital herpes. The ointment ...
Read More

Alembic Pharma acquires US based West Caldwell

Alembic Pharmaceuticals has acquired a US based generic drug developer West Caldwell, New Jersey. With this acquisition Alembic will now ...
Read More

Alembic Pharma plans expansion programme at Panelav unit

Alembic Pharma is planning to expand its existing unit in Panelav village in Halol Tehsil in Panchmahal district of Gujarat ...
Read More
Personnel
Amit Shah – Sr. Manager
R S Joshi – Asst. Gen. Mgr
Chirayu Amin – CEO
Mitanshu Shah – Senior Vice President Finance
Ahalgama Jignesh – Formulation and Development
Dr. Abhay Gaitonde – Senior Vice President (Formulations)
Fomi Dwivedi – Assistant Manager Learning Development
Virendra Srivastava – Associate Vice President – Regulatory Affairs
Piyush Kunal – Assistant General Manager Planning & Logistics
Vishal Kale – Production Executive
Vivek V – Product Manager
Shriniwas Shantkumar Yeramwar – Assistant Manager – Project Management
Sanjay Katre – Quality Compliance Manager
Vivek Avasatthi – Research Scientist
Mitesh Shah – Manager
Mayuri Sathe – Sr Product Manager
Debashish Kar, – Head Quality Assurance
Ramanbhai Amin – Director
Malika Chirayu Amin – Director
Udit Chirayu Amin – Director
Sameer Subhash Khera – Director

 

Other Office Address

Plant Survey No. 842 /843, Village Kharkhadi Padra Village Karkhadi 391450 Padra Vadodara Gujarat
Plant Plot No. 21, 22 , EPIP – Phase I Jhamajri , Baddi, Tehsil Baddi 173205 Solan Himachal Pradesh
Plant Panelav, Tal. Halol, Panelav 389356 Halol Panchmahals Gujarat
Plant Alembic Road Vadodara 390003 Vadodara Gujarat Tel : 0265-2280550 /880 Fax : 2281229 Email : alembic@alembic.co.in
Corp Office Alembic Road Vadodara 390003 Vadodara Gujarat 0265-2280550 / 880 2281229

 

Be the first to comment

Leave a Reply

Your email address will not be published.


*